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ORIGINAL ARTICLE
INTRODUCTION
Acalculous cholecystitis occurs more often in
human immunodeficiency virus (HIV) patients
compare to general population.1,2 This gallbladder
disorder, uniquely, has no apparent clinical signs or
symptoms. Symptom found commonly includes mild
abdominal pain. In order to established diagnosis,
ultrasonography (USG) is still the diagnostic tools of
choice due to its non-invasive characteristic, relatively
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ABSTRACT
Background: Acalculous cholecystitis is commonly found in patients with human immunodeficiency
virus (HIV) compared to general population. Surprisingly, the signs and symptoms are unremarkable.
On the other hand, HIV/hepatitis C virus (HCV) co-infection is a common finding. The aim of this study
was to evaluate whether HCV infection has any influence to HIV patients concerning acalculous
cholecystitis prevalence.
Method: A cross-sectional study was performed in HIV/HCV patients who visited AIDS study group
clinic at Cipto Mangunkusumo hospital from September 2008 to February 2009. The patients who met
the criteria were examined physically and underwent abdominal ultrasonography. Routine blood count,
alanine aminotranferase, aspartate aminotransferase, cluster of differentiation 4 (CD4) and serum
albumin were recorded.
Results: Of 63 patients underwent ultrasonography examination, we found acalculous cholecystitis
in 33 patients (52.3%), cholelithiasis and cholecystitis in 2 patients, and 28 patients were considered
normal. Patients with CD4 less than 200 cells, tend to have acalculous cholecystitis more than those who
had CD4 more than 200 cells.
Conclusion: The prevalence of acalculous cholecystitis among HIV/HCV co-infection is higher
compared to those with HIV infection alone.
Keywords: acalculous cholecystitis, HIV/HCV co-infection, CD4
low-cost tool, and its availability in most health care
centers. Hepatitis C co-infection in HIV patients
occurs frequently.3,4,5
Therefore, we would like to observe whether there
is any influence of concomitant hepatitis C virus (HCV)
infection on the prevalence of acalculous cholecystitis
in HIV patients admitted to Cipto Mangunkusumo
hospital. The aim of this study was to understand the
prevalence of concomitant HCV infection on the
occurrence of acalculous cholecystitis in HIV patients,
by using USG examination.
METHOD
Subjects were patients with combined infection of
HIV/HCV who were being taken care of an AIDS
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study group at Cipto Mangunkusumo hospital from 
September 2008 to February 2009. HIV patients were  
patients who had shown positive anti-HIV of  
serologic tests results and HCV patients were patients  
who had shown a positive anti-HCV of serologic tests  
result. 
This was a cross-sectional study. The inclusion 
criteria were adult patients with combined HIV/HCV 
infection. The exclusion criteria were patients with 
positive hepatitis B infection (positive HbsAg), ascites, 
hypoalbuminemia (serum albumin < 3 g/dL); and 
decompensated cirrhosis patients. 
Interviews were performed to all patients who met  
the above-mentioned criteria. We asked questions  
including history of fever, epigastric pain, upper right  
abdominal pain, or weight loss in the last 3 months.  
Physical examination was also performed to confirm  
fever, ascites, pain on the upper right abdomen on  
palpation, palpable mass in the epigastrium/upper right  
abdomen, and jaundice. The laboratory examinations  
includes routine blood test (hemoglobin, leukocytes,  
platelets), chemical pathology tests (ALT, AST, serum  
albumin), and serology tests (anti HIV, anti HCV, and  
CD4). Abdominal USG was performed at the  
Hepatology Procedure Room. Patients had at least  
6-hours fasting prior to the USG examination. From  
the gallbladder examination, we obtained the data of  
gallbladder’s size, contour, wall, and contents. Patients  
were diagnosed as having cholecystitis if the  
gallbladder wall thickness was 3 mm or more and  
acalculous cholecystitis was diagnosed if such criteria  
were fulfilled without any mass shadow inside the  
gallbladder.6,7,8 
Samples were collected from outpatients of AIDS 
study group clinic at Cipto Mangunkusumo hospital in 
September 2008 - March 2009. The minimum required 
sample size is 62 patients. 
 
RESULTS 
There were 63 patients being observed, 53 patients  
were male with range age 22 to 42 years. Symptoms  
complained by the patients included fever in nine  
patients, epigastric or upper right abdominal pain in  
seven patients, and nausea or loss of appetite in five  
patients. By physical examination we didn’t found any  
significant abnormality in all patients. Fever,  
abdominal tenderness, jaundice, ascites, or abdominal  
mass were not found. All of the patients were on their  
HIV antiviral treatment. 
Anemia (hemoglobin < 12 g/dL) was found in 9  
patients, while 54 patients had hemoglobin > 12 g/dL  
in the last three months. From leukocytes count,  
we found 21 patients with leukopenia (leukocytes  
< 5,000/mm3), two patients with leukocytosis  
(leukocyte > 10,000/mm3), the other 40 patients had 
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normal leukocyte count. Thrombocytopenia 
(platelets < 150,000/mm3) was found in seven 
patients and 56 patients had normal platelet 
counts. 
AST level above the normal limit were found in  
29 patients with two patients were diagnosed as hav- 
ing acalculous cholecystitis (6.8%). Increased ALT  
level was found in 45 patients, 11 of whom were with  
acalculous cholecystitis (24.4%). Increased level of  
both AST and ALT were found in 26 patients, 13 of  
whom were diagnosed with acalculous cholecystities.  
Of 63 patients, the CD4 was approximately between  
21-741 cells. Patients with CD4 more than 200 cells  
were 39 patients and 24 patients were with CD4  
< 200 cells. 
Of 63 patients who underwent the USG 
examination, we revealed findings such as no  
gallbladder abnormality in 28 patients, stone contents  
inside the gallbladder with concomitant wall thickness  
in 2 patients, contour abnormality in 4 patients. Wall  
thickening > 3 mm in 33 patients, 10 patients were  
confirmed to have sludge inside their gallbladder.  
The 33 (52.3%) patients indeed were defined as  
acalculous cholecystitis patients 16 (66.6%) of them  
had CD4 < 200 cells, and 17 (43.5%) patients had  
CD4 > 200 cells. 
33  
 
Table 1. Patients based on their sex and age group  
Age group Sex 20-29 30-39 > 40 Total 
Male 24 28 1 53 
Female 7 3 0 10 
 
Table 2. Patients characteristics  
Parameter n 
Symptoms  
 Fever 9 
 Abdominal pain 7 
 Nausea, loss of appetite 5 
 Without symptom  42 
Hemoglobin (g/dL)  
 < 12 9 
 > 12 54 
Leukocytes (per mm3)  
 Leukopenia (< 5,000) 21 
 Leukocytosis (< 10,000) 2 
 Normal 40 
Platelets (per mm3)  
 < 150,000 7 
 > 150,000 56 
Gallbladder ultrasonography  
 Normal 28 
 Stone and wall thickenings 2 
 Wall thickening and sludge 10 
 Only wall thickening  23 
 
Table 3. Result of CD4 serology 
CD4 amount Number of patients 
Acalculous cholecystitis 
n (%) 
CD4 < 200 cells 24 16 (66.6) 
CD4 > 200 cells 39 17 (43.5) 
 
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy34
Bambang Sutopo, Unggul Budihusodo, Irsan Hasan,  et  al
DISCUSSION
Young patients were dominant based on the age
group distribution. There was only one patient who
was older than 40 years old, the others were younger
than 40 years old. It confirms the idea that the spread
of HIV in Jakarta mainly through unsafe injection
among drug users. Injecting drug users typically share
one needle to the whole groups and they are usually
the youth aged under 40 years old.4
Most of the patients have no complaint; there were
42 (66.6%) asymptomatic patients. About 9 (14.2%)
patients had complaints of recurrent fever. Abdominal
pain was complaint by 7 (11%) patients, and nausea
with appetite loss was found in 5 (7.9%) patients. Such
finding were relevant to the prior study conducted by
Thuluvath et al indicating that there was only 12%
abdominal pain among the HIV patients.10
Based on the routine blood examination, we found
54 patients with hemoglobin > 12 g/dL; while
9 patients had hemoglobin < 12 g/dL. It suggests that
most patients were generally in a quite good condition,
which obviously observed based on few complaints
by small minority of the patients and most patients had
a quite good hemoglobin level. Whether this was caused
by the HIV treatment or not, it will need further study
to confirm.
The liver enzyme tests suggested an increase of
ALT level in 45 patients and 11 (24.4%) patients found
to have acalculous cholecystitis. There were increased
AST level in 29 patients, of whom acalculous
cholecystitis only found in 2 (6.8%) patients. The
interesting findings were the increase of both AST and
ALT which occurred in 26 patients and 13 (50%) of
them were suffering acalculous cholecystitis. Whether
these patients with increased of both AST and ALT
are vulnerable to suffer acalculous cholecystitis also
needs further studies. Subjects with CD4 value > 200
cells were 39 patients, 17 (43.5%) of them were
diagnosed acalculous cholecystitis. In contrast,
24 patients were with CD4 < 200 cells and 16 (66.6%)
of them had acalculous cholecystitis. Such findings is
relevant to the study by Waspodo et al, which found
68.3% acalculous cholecystitis.3 Based on this fact, it
is obvious that the lower CD4 level in the patients,
there is greater tendency of having acalculous chole-
cystitis.
Based on abdominal USG examination of 63
patients found normal gallbladder in 28 (44.4%)
patients, cholecystitis and cholelithiasis in 2 (3.1%)
patients and acalculous cholecystitis in 33 (52.3%)
patients. Such findings was higher than results reported
by Gianawati, in which only 27.9% of the population
had acalculous cholecystitis.1 Such difference is
possible since Gianawati only observed the HIV
patients, while our study evaluated patients with
co-infection of HIV and HCV.
CONCLUSION
Co-infection of hepatitis C virus in HIV patients
increases the prevalence of acalculous cholecystitis.
In this case, we could conclude that, the lower CD4
level in the patients, there is greater tendency of
having acalculous cholecystitis.
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